A new approach to cancer treatment, known as plug-and-play CAR-T cell therapy, may potentially transform the field of cancer immunotherapy. This therapy is part of a broader area of research that involves using the body's immune system to fight cancer, including gene therapy, immune modulation, and adoptive T-cell therapies. The development and application of these treatments are being explored, with potential implications for enhancing precision and effectiveness in cancer treatment.